Literature DB >> 10545320

The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains.

M J Berardi1, C Sun, M Zehr, F Abildgaard, J Peng, N A Speck, J H Bushweller.   

Abstract

BACKGROUND: CBFA is the DNA-binding subunit of the transcription factor complex called core binding factor, or CBF. Knockout of the Cbfa2 gene in mice leads to embryonic lethality and a profound block in hematopoietic development. Chromosomal disruptions of the human CBFA gene are associated with a large percentage of human leukemias.
RESULTS: Utilizing nuclear magnetic resonance spectroscopy we have determined the three-dimensional fold of the CBFA Runt domain in its DNA-bound state, showing that it is an s-type immunoglobulin (Ig) fold. DNA binding by the Runt domain is shown to be mediated by loop regions located at both ends of the Runt domain Ig fold. A putative site for CBFB binding has been identified; the spatial location of this site provides a rationale for the ability of CBFB to modulate the affinity of the Runt domain for DNA.
CONCLUSIONS: Structural comparisons demonstrate that the s-type Ig fold found in the Runt domain is conserved in the Ig folds found in the DNA-binding domains of NF-kappaB, NFAT, p53, STAT-1, and the T-domain. Thus, these proteins form a family of structurally and functionally related DNA-binding domains. Unlike the other members of this family, the Runt domain utilizes loops at both ends of the Ig fold for DNA recognition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545320     DOI: 10.1016/s0969-2126(00)80058-1

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  29 in total

1.  Automated protein fold determination using a minimal NMR constraint strategy.

Authors:  Deyou Zheng; Yuanpeng J Huang; Hunter N B Moseley; Rong Xiao; James Aramini; G V T Swapna; Gaetano T Montelione
Journal:  Protein Sci       Date:  2003-06       Impact factor: 6.725

2.  Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).

Authors:  T L Gu; T L Goetz; B J Graves; N A Speck
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.

Authors:  T L Goetz; T L Gu; N A Speck; B J Graves
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.

Authors:  Claire K Inman; Na Li; Paul Shore
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

6.  Site-specific evolutionary rates in proteins are better modeled as non-independent and strictly relative.

Authors:  Andrew D Fernandes; William R Atchley
Journal:  Bioinformatics       Date:  2008-07-28       Impact factor: 6.937

Review 7.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

8.  Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML.

Authors:  A Stengel; W Kern; M Meggendorfer; N Nadarajah; K Perglerovà; T Haferlach; C Haferlach
Journal:  Leukemia       Date:  2017-07-28       Impact factor: 11.528

9.  Biochemical and functional evidence of p53 homology is inconsistent with molecular phylogenetics for distant sequences.

Authors:  Andrew D Fernandes; William R Atchley
Journal:  J Mol Evol       Date:  2008-06-17       Impact factor: 2.395

10.  Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancer.

Authors:  Sarion R Bowers; Fernando J Calero-Nieto; Stephanie Valeaux; Narcis Fernandez-Fuentes; Peter N Cockerill
Journal:  Nucleic Acids Res       Date:  2010-05-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.